Showing results (521-530 of 624) with videos related to
Sort By:
Pageof 63
Bone Marrow Transplantation|March 7, 2003
Hepatitis reactivation and liver failure in haemopoietic stem cell transplants for hepatitis B virus (HBV)/hepatitis C virus (HCV) positive recipients: a retrospective study by the Italian group for blood and marrow transplantationA Locasciulli, B Bruno, E P Alessandrino, et al.Leukemia|April 1, 1993
Mitoxantrone, etoposide and intermediate-dose Ara-C (MEC): an effective regimen for poor risk acute myeloid leukemiaA Spadea, M C Petti, P Fazi, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 2013
Network analysis identifies an HSP90-central hub susceptible in ovarian cancerHanqing Liu, Fang Xiao, Ilya G Serebriiskii, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 24, 2005
Acute myelogenous leukemia in elderly patients not eligible for intensive chemotherapy: the dark side of the moonR Latagliata, V Bongarzoni, I Carmosino, et al.Plos One|May 3, 2011
Multifaceted intervention by the Hsp90 inhibitor ganetespib (STA-9090) in cancer cells with activated JAK/STAT signalingDavid A Proia, Kevin P Foley, Tim Korbut, et al.Investigational New Drugs|January 10, 2012
Synergistic activity of the Hsp90 inhibitor ganetespib with taxanes in non-small cell lung cancer modelsDavid A Proia, Jim Sang, Suqin He, et al.Blood|November 24, 1999
Treatment and clinical management of primary mediastinal large B-cell lymphoma with sclerosis: MACOP-B regimen and mediastinal radiotherapy monitored by (67)Gallium scan in 50 patientsP L Zinzani, M Martelli, M Magagnoli, et al.Leukemia|February 24, 2001
Idarubicin intensified BUCY2 regimen in allogeneic unmanipulated transplant for high-risk hematological malignanciesA Mengarelli, A P Iori, C Guglielmi, et al.Leukemia|November 22, 1997
Management of infective complications in patients with advanced hematologic malignancies in home careC Girmenia, M L Moleti, C Cartoni, et al.Oncoimmunology|April 9, 2016
Repeated PD-1/PD-L1 monoclonal antibody administration induces fatal xenogeneic hypersensitivity reactions in a murine model of breast cancerChristine Mall, Gail D Sckisel, David A Proia, et al.Pageof 63